A modern interdisciplinary branch of science that combines disease biology, systems biology including genomics, transcriptomics, proteomics, metabolomics, metabonomics, culturomics, immunomics, regulomics, phenomics, computational biology, and high throughput data analysis is called Systems Medicine. It integrated with biobanking and animal studies to provide a comprehensive understanding of various aspects of disease studies.

The traditional medicine technique approach lacks mechanistic understanding of molecular and cellular networks. To underlying molecular descriptors using large patient cohorts for better understanding of disease prevention, prediction, diagnosis and treatment, this branch of science is very important.

Programme of Study

  • PhD (Systems Medicine)

This courses is to make a strong foundation in systems
medicine. The credit courses will be divided in the first two semesters of the programme that include both basic and applied aspects of the course.

What is the qualification criteria for the admission in Ph.D. course ?

    Jerrysingh The eligibility criteria for the admission in Ph. D. course is Master’s degree (M.Sc., MBBS, M.VSc, M. Pharma)/ B.Tech, B. Pharma or a professional degree declared equivalent to the Master’s degree by the corresponding statutory regulatory body, with at least 55% marks in aggregate or its equivalent grade ‘B’ in the UGC 7 point scale (or an equivalent grade in a point scale wherever grading system is followed); or an equivalent degree from a foreign educational institution.

      what are the cutting edge areas for research in this field of Systems Medicine ?

        AnmolPathak The competitive and vibrant PhD programme in Systems Medicine embarks on creating a robust academic research foundation in the following cutting-edge areas:
        i. Advances in systems biology and biological data
        ii. Molecular basis of human diseases
        iii. Advances in genomics and transcriptomics
        iv. Advances in proteomics and metabolomics
        v. Advances in immunomics and pathomics
        vi. Ethics in research, regulatory compliances, IPR and entrepreneurship

          a month later